{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:10:40Z","timestamp":1779433840623,"version":"3.53.1"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:p>\n                    Patients with chronic kidney disease frequently exhibit abnormalities in their lipid metabolism. Confounding factors in observational studies often obscure the causal relationship between these 2 diseases. This study investigated the causal relationships between genetically predicted levels of 6 key lipid parameters (total cholesterol (TC), triglycerides (TG), HDL-C, low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (ApoA1), and apolipoprotein B (ApoB)) and circulating kidney injury molecule 1 (KIM-1) levels, using a comprehensive bidirectional Mendelian randomization (MR) analysis. Using genome-wide association study data, the primary analysis used the inverse-variance weighted (IVW) method, supported by MR-Egger regression and a weighted median estimator. Sensitivity analyses including heterogeneity, pleiotropy tests, leave-one-out, and reverse causality analyses were conducted. The IVW model revealed the following: TG (odds ratio (OR): 1.1843, 95% confidence interval (CI): 1.1178\u20131.2547,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u20059.5894e\u221209), TC (OR: 1.1096, 95% CI: 1.0178\u20131.2095,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0182), and ApoA1 (OR: 1.1820, 95% CI: 1.0741\u20131.3007,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0007) were found to have significant causal relationships with KIM-1, a biomarker of kidney tubular injury, and may be risk factors for renal tubular injury; No significant causal associations were observed between high-density lipoprotein cholesterol (HDL-C), (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.2929), LDL-C (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.2178), ApoB (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.1836), and KIM-1; Horizontal pleiotropy was detected for ApoA1 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0208). However, sensitivity analyses confirmed the robustness of the results after the removal of outliers; significant heterogeneity was observed across all lipid parameters (Cochran\n                    <jats:italic toggle=\"yes\">Q P<\/jats:italic>\n                    \u2005&lt;\u2005.05), which necessitated the use of random-effects IVW models; and reverse causality analyses (MR-Egger intercept\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05, Steiger filtering) confirmed no evidence of reverse causation between lipid profiles and KIM-1. TG, HDL-C, and ApoA1 levels may be risk factors for renal tubular injury. However, no significant causal relationships were observed between HDL-C, LDL-C, and ApoB levels and renal tubular injury. To further explore the underlying mechanisms of the associations between TG, HDL-C, ApoA1, and KIM-1 and to inform lipid management strategies in tubulopathy-related conditions.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046279","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:03:27Z","timestamp":1766203407000},"page":"e46279","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of tubular injury with lipid metabolism: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4075-5597","authenticated-orcid":false,"given":"Keqin","family":"Zhao","sequence":"first","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Qian","sequence":"additional","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7867-6898","authenticated-orcid":false,"given":"Xiaobei","family":"Ma","sequence":"additional","affiliation":[{"name":"Graduate School, China Academy of Chinese Medical Sciences, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"e13945","DOI":"10.1111\/eci.13945","article-title":"The impact of metabolic syndrome on chronic kidney disease development. Insights from a big prospective study.","volume":"53","author":"Fanaei","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"e00027","DOI":"10.1097\/IMNA-D-22-00027","article-title":"Research progress on the potential mechanisms of acute kidney injury and chronic kidney disease induced by proton pump inhibitors.","volume":"10","author":"Song","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/jpm12040548","article-title":"Emerging biomarkers for early detection of chronic kidney disease.","volume":"12","author":"Mizdrak","year":"2022","journal-title":"J Personalized Med"},{"key":"R4-20260522","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00019","article-title":"New insights into a novel metabolic biomarker and therapeutic target for chronic kidney disease.","volume":"11","author":"Chen","year":"2024","journal-title":"Integr Med Nephrol Androl"},{"key":"R5-20260522","first-page":"1","article-title":"Systems biology and novel biomarkers for the early detection of diabetic kidney disease.","volume":"149","author":"Villalvazo","year":"2025","journal-title":"Nephron"},{"key":"R6-20260522","first-page":"253","article-title":"Effects of metaraminol and norepinephrine on hemodynamics and kidney function in a miniature pig model of septic shock.","volume":"12","author":"Li","year":"2024","journal-title":"J Transl Internal Med"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"e00023","DOI":"10.1097\/IMNA-D-22-00023","article-title":"Clinical characteristics and chinese medicine therapy of chronic kidney disease combined with cardiovascular disease.","volume":"10","author":"Zhu","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"R8-20260522","first-page":"8","article-title":"Lipid disorders in patients with renal failure: role in cardiovascular events and progression of chronic kidney disease.","volume":"6","author":"Visconti","year":"2016","journal-title":"J Clin Transl Endocrinol"},{"key":"R9-20260522","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1624077","article-title":"The role of natural products in improving lipid metabolism disorder-induced mitochondrial dysfunction of diabetic kidney disease.","volume":"16","author":"Deng","year":"2025","journal-title":"Front Physiol"},{"key":"R10-20260522","first-page":"1","article-title":"Association between LXR-\u03b1 and ABCA1 gene polymorphisms and the risk of diabetic kidney disease in patients with type 2 diabetes mellitus in a chinese han population.","volume":"2020","author":"Liu","year":"2020","journal-title":"J Diabetes Res"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"103210","DOI":"10.1016\/j.autrev.2022.103210","article-title":"Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases.","volume":"21","author":"Chen","year":"2022","journal-title":"Autoimmun Rev"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"1093397","DOI":"10.3389\/fphar.2022.1093397","article-title":"Protective effect of natural products in the metabolic-associated kidney diseases via regulating mitochondrial dysfunction.","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3945\/ajcn.115.118216","article-title":"Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.","volume":"103","author":"Haycock","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/aje\/kwj062","article-title":"Limits to causal inference based on mendelian randomization: a comparison with randomized controlled trials.","volume":"163","author":"Nitsch","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/add.14038","article-title":"Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.","volume":"113","author":"Katikireddi","year":"2018","journal-title":"Addiction"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","article-title":"Statistical methods for Mendelian randomization in genome-wide association studies: a review.","volume":"20","author":"Boehm","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1038\/s41467-022-34164-1","article-title":"Mendelian randomization accounting for complex correlated horizontal pleiotropy while elucidating shared genetic etiology.","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/0118715303288685240808073238","article-title":"Mendelian randomization studies: opening a new window in the study of metabolic diseases and chronic kidney disease.","volume":"25","author":"Liang","year":"2025","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.ajkd.2017.06.011","article-title":"HDL cholesterol, LDL cholesterol, and triglycerides as risk factors for CKD: a Mendelian randomization study.","volume":"71","author":"Lanktree","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7861\/clinmed.cg.20.2","article-title":"Chronic kidney disease in adults: assessment and management.","volume":"20","author":"Forbes","year":"2020","journal-title":"Clin Med"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease.","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"R24-20260522","first-page":"255","article-title":"Chinese guidelines for diagnosis and treatment of diabetic kidney disease.","year":"2021","journal-title":"Chin J Nephrol"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R26-20260522","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration.","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-025-01671-4","article-title":"Association of antihypertensive drug target genes with Alzheimer\u2019s disease: a mendelian randomization study.","volume":"17","author":"Zheng","year":"2025","journal-title":"Alzheimer's Res Ther"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression.","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R29-20260522","doi-asserted-by":"crossref","first-page":"64","DOI":"10.17691\/stm2021.13.3.08","article-title":"Kidney injury molecule 1 (KIM-1): a multifunctional glycoprotein and biological marker (review).","volume":"13","author":"Karmakova","year":"2021","journal-title":"Sovrem Tehnol Med"},{"key":"R30-20260522","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/854070","article-title":"Kidney injury molecule-1 and cardiovascular diseases: from basic science to clinical practice.","volume":"2015","author":"Medi\u0107","year":"2015","journal-title":"Biomed Res Int"},{"key":"R31-20260522","doi-asserted-by":"crossref","first-page":"103373","DOI":"10.1016\/j.amsu.2022.103373","article-title":"Analysis of mRNA and protein kidney injury molecule-1 (KIM-1) expression in a kidney model during the initiation phase of ischemia reperfusion injury.","volume":"75","author":"Dase","year":"2022","journal-title":"Ann Med Surg"},{"key":"R32-20260522","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1038\/s41467-023-40036-z","article-title":"A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury.","volume":"14","author":"Yang","year":"2023","journal-title":"Nat Commun"},{"key":"R33-20260522","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat Biotechnol"},{"key":"R34-20260522","doi-asserted-by":"crossref","first-page":"47","DOI":"10.11648\/j.sjcm.20211002.16","article-title":"The Significance of urinary RBP and KIM-1 determination in cisplatin \u2013 induced acute kidney injury.","volume":"10","author":"Haoqiang","year":"2021","journal-title":"SJCM"},{"key":"R36-20260522","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1172\/JCI45361","article-title":"Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis.","volume":"123","author":"Humphreys","year":"2013","journal-title":"J Clin Invest"},{"key":"R37-20260522","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/0886022X.2017.1419974","article-title":"The effect of cholesterol overload on mouse kidney and kidney-derived cells.","volume":"40","author":"Honzumi","year":"2018","journal-title":"Ren Fail"},{"key":"R38-20260522","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1159\/000490170","article-title":"Depletion of cholesterol reduces ENaC activity by decreasing phosphatidylinositol-4,5-bisphosphate in microvilli.","volume":"47","author":"Zhai","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R39-20260522","doi-asserted-by":"crossref","first-page":"112560","DOI":"10.1016\/j.intimp.2024.112560","article-title":"Morroniside attenuates podocytes lipid deposition in diabetic nephropathy: a network pharmacology, molecular docking and experimental validation study.","volume":"138","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R40-20260522","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1074\/jbc.275.16.12003","article-title":"Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins.","volume":"275","author":"Hammad","year":"2000","journal-title":"J Biol Chem"},{"key":"R42-20260522","doi-asserted-by":"crossref","first-page":"e41620","DOI":"10.1016\/j.heliyon.2024.e41620","article-title":"Lipidomics-based natural products for chronic kidney disease treatment.","volume":"11","author":"Zhang","year":"2025","journal-title":"Heliyon"},{"key":"R43-20260522","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nm0410-396","article-title":"Endoplasmic reticulum stress and atherosclerosis.","volume":"16","author":"Hotamisligil","year":"2010","journal-title":"Nat Med"},{"key":"R44-20260522","doi-asserted-by":"crossref","first-page":"9942152","DOI":"10.1155\/2021\/9942152","article-title":"Morroniside promotes PGC\u20101\u03b1\u2010mediated cholesterol efflux in sodium palmitate or high glucose\u2010induced mouse renal tubular epithelial cells.","volume":"2021","author":"Gao","year":"2021","journal-title":"Biomed Res Int"},{"key":"R45-20260522","article-title":"Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"R46-20260522","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/mmr.2023.12980","article-title":"Mechanism of dioscin ameliorating renal fibrosis through NF\u2011\u03baB signaling pathway\u2011mediated inflammatory response.","volume":"27","author":"Wang","year":"2023","journal-title":"Mol Med Rep"},{"key":"R47-20260522","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2478\/jtim-2023-0129","article-title":"Circulating exosome long non-coding RNAs are associated with atrial structural remodeling by increasing systemic inflammation in atrial fibrillation patients.","volume":"12","author":"Yuan","year":"2024","journal-title":"J Transl Internal Med"},{"key":"R48-20260522","doi-asserted-by":"crossref","first-page":"F517","DOI":"10.1152\/ajprenal.00085.2021","article-title":"LncRNA GAS5 protects against TGF-\u03b2-induced renal fibrosis via the Smad3\/miRNA-142-5p axis.","volume":"321","author":"Zhang","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"R49-20260522","doi-asserted-by":"crossref","first-page":"2793823","DOI":"10.1155\/2021\/2793823","article-title":"Zishen qingre tongluo formula improves renal fatty acid oxidation and alleviated fibrosis via the regulation of the TGF\u2010\u03b21\/Smad3 signaling pathway in hyperuricemic nephrology rats.","volume":"2021","author":"Liu","year":"2021","journal-title":"Biomed Res Int"},{"key":"R50-20260522","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03122-4","article-title":"High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction.","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis"},{"key":"R51-20260522","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.796724","article-title":"The programmed cell death of macrophages, endothelial cells, and tubular epithelial cells in sepsis-AKI.","volume":"8","author":"Li","year":"2021","journal-title":"Front Med"},{"key":"R52-20260522","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.3390\/ijms20143406","article-title":"Kidney injury molecule-1 is upregulated in renal lipotoxicity and mediates palmitate-induced tubular cell injury and inflammatory response.","volume":"20","author":"Zhao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R53-20260522","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/7300030","article-title":"Omega-3 fatty acids inhibit endoplasmic reticulum (ER) stress in human coronary artery endothelial cells.","volume":"2023","author":"Warda","year":"2023","journal-title":"J Food Biochem"},{"key":"R54-20260522","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s10020-024-00808-9","article-title":"Endoplasmic reticulum stress and therapeutic strategies in metabolic, neurodegenerative diseases and cancer.","volume":"30","author":"Yuan","year":"2024","journal-title":"Mol Med"},{"key":"R55-20260522","doi-asserted-by":"crossref","first-page":"e10572","DOI":"10.34172\/npj.2023.10572","article-title":"Kidney injury molecule-1; is it a predictive marker for renal diseases?","volume":"12","author":"Anandkumar","year":"2023","journal-title":"J Nephropharmacol"},{"key":"R56-20260522","doi-asserted-by":"crossref","first-page":"44059","DOI":"10.18632\/oncotarget.6623","article-title":"KIM-1\/TIM-1 in proximal tubular cell immune response.","volume":"6","author":"Brooks","year":"2015","journal-title":"Oncotarget"},{"key":"R57-20260522","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/imm.12844","article-title":"Lipid homeostasis and inflammatory activation are disturbed in classically activated macrophages with peroxisomal \u03b2\u2010oxidation deficiency.","volume":"153","author":"Geric","year":"2018","journal-title":"Immunology"},{"key":"R58-20260522","doi-asserted-by":"crossref","first-page":"1542938","DOI":"10.3389\/fnmol.2025.1542938","article-title":"Impaired peroxisomal beta-oxidation in microglia triggers oxidative stress and impacts neurons and oligodendrocytes.","volume":"18","author":"Tawbeh","year":"2025","journal-title":"Front Mol Neurosci"},{"key":"R59-20260522","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/jmcb\/mjs043","article-title":"MAP kinases and histone modification.","volume":"4","author":"Suganuma","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"R60-20260522","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cells11050844","article-title":"Molecular mechanism of lipotoxicity as an interesting aspect in the development of pathological states\u2014current view of knowledge.","volume":"11","author":"Lipke","year":"2022","journal-title":"Cells"},{"key":"R61-20260522","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s13238-014-0089-1","article-title":"Mitochondria-mediated apoptosis in mammals.","volume":"5","author":"Xiong","year":"2014","journal-title":"Protein Cell"},{"key":"R62-20260522","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-020-00349-0","article-title":"The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer.","volume":"6","author":"Jiang","year":"2020","journal-title":"Cell Death Discov"},{"key":"R63-20260522","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1681\/ASN.2013020161","article-title":"A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury.","volume":"25","author":"Ajay","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R64-20260522","doi-asserted-by":"crossref","first-page":"113634","DOI":"10.1016\/j.biopha.2022.113634","article-title":"Leveraging knowledge of HDLs major protein ApoA1: structure, function, mutations, and potential therapeutics","volume":"154","author":"Bhale","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R65-20260522","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2478\/jtim-2022-0035","article-title":"Gas chromatography-mass spectrometry pilot study to identify volatile organic compound biomarkers of childhood obesity with dyslipidemia in exhaled breath.","volume":"11","author":"Xu","year":"2023","journal-title":"J Transl Internal Med"},{"key":"R66-20260522","doi-asserted-by":"crossref","first-page":"e18364","DOI":"10.1111\/jcmm.18364","article-title":"Molecular mechanism of renal lipid accumulation in diabetic kidney disease.","volume":"28","author":"Fang","year":"2024","journal-title":"J Cell Mol Med"},{"key":"R67-20260522","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphys.2018.00343","article-title":"Tangshen formula attenuates diabetic nephropathy by promoting ABCA1-mediated renal cholesterol efflux in db\/db mice.","volume":"9","author":"Liu","year":"2018","journal-title":"Front Physiol"},{"key":"R68-20260522","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/dna.2015.2892","article-title":"ApoM suppresses TNF-\u03b1-Induced expression of ICAM-1 and VCAM-1 through inhibiting the activity of NF-\u03baB.","volume":"34","author":"Gao","year":"2015","journal-title":"DNA Cell Biol"},{"key":"R69-20260522","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/brv.12948","article-title":"Deciphering structural aspects of reverse cholesterol transport: mapping the knowns and unknowns.","volume":"98","author":"Sacher","year":"2023","journal-title":"Biol Rev Camb Philos Soc"},{"key":"R70-20260522","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma.","volume":"20","author":"Huang","year":"2014","journal-title":"Nat Med"},{"key":"R71-20260522","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2011.11.020","article-title":"Dynamic dissociating homo-oligomers and the control of protein function.","volume":"519","author":"Selwood","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"R72-20260522","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/jpm13040577","article-title":"Expression of angiopoetin-like protein-4 and kidney injury molecule-1 as preliminary diagnostic markers for diabetes-related kidney disease: a single center-based cross-sectional study.","volume":"13","author":"Bano","year":"2023","journal-title":"J Personalized Med"},{"key":"R73-20260522","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2215\/CJN.11710919","article-title":"Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease.","volume":"15","author":"Tan","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"R74-20260522","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/ijms20051202","article-title":"Plasma levels of Pre\u03b21-HDL are significantly elevated in non-dialyzed patients with advanced stages of chronic kidney disease.","volume":"20","author":"Kuchta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R75-20260522","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/ijms24010318","article-title":"The Apparent organ-specificity of amyloidogenic ApoA-I variants is linked to tissue-specific extracellular matrix components.","volume":"24","author":"Del Giudice","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R76-20260522","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1089\/hum.2024.166","article-title":"Overexpression of ABCA1 in carotid endothelium of hyperlipidemic rabbits modulates vascular inflammation.","volume":"36","author":"Wacker","year":"2025","journal-title":"Hum Gene Ther"},{"key":"R79-20260522","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/ijms24021415","article-title":"Toll-like receptor 4 in acute kidney injury.","volume":"24","author":"Vall\u00e9s","year":"2023","journal-title":"IJMS"},{"key":"R80-20260522","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00125-007-0718-9","article-title":"Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.","volume":"50","author":"Hoang","year":"2007","journal-title":"Diabetologia"},{"key":"R81-20260522","article-title":"The association of apolipoprotein B with chronic kidney disease in the Chinese population.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Endocrinol"},{"key":"R82-20260522","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00732","article-title":"The vicious cycle of renal lipotoxicity and mitochondrial dysfunction.","volume":"11","author":"Ge","year":"2020","journal-title":"Front Physiol"},{"key":"R83-20260522","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/0886022X.2016.1193816","article-title":"Kidney injury molecule-1 in kidney disease.","volume":"38","author":"Yin","year":"2016","journal-title":"Ren Fail"},{"key":"R84-20260522","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000513166","article-title":"Kidney injury molecule-1 and periostin urinary excretion and tissue expression levels and association with glomerular disease outcomes.","volume":"1","author":"Wu","year":"2021","journal-title":"Glomerular Dis"},{"key":"R85-20260522","doi-asserted-by":"crossref","first-page":"e011162","DOI":"10.1161\/JAHA.118.011162","article-title":"Association between serum high\u2010density lipoprotein cholesterol levels and progression of chronic kidney disease: results from the KNOW\u2010CKD.","volume":"8","author":"Nam","year":"2019","journal-title":"JAHA"},{"key":"R86-20260522","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.644208","article-title":"Association between renal dysfunction and low HDL cholesterol among the elderly in China.","volume":"8","author":"You","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R87-20260522","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/biomedicines9070729","article-title":"HDL dysfunctionality: clinical relevance of quality rather than quantity.","volume":"9","author":"Bonizzi","year":"2021","journal-title":"Biomedicines"},{"key":"R88-20260522","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3390\/nu13041165","article-title":"Functional food and bioactive compounds on the modulation of the functionality of HDL-C: a narrative review.","volume":"13","author":"Luna-Castillo","year":"2021","journal-title":"Nutrients"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:03:35Z","timestamp":1779433415000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":83,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046279","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-05-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}